PeptiCRAd-1

· Valo Therapeutics Oy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PeptiCRAd-1, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer [Phase 1]